# Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pharmacotherapy-considerations-with-finerenone-in-the-treatment-of-chronic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emily Ashjian,Megan M. Clarke,Kristen Pogue |
| Citations | 19 |
| DOI | 10.1093/ajhp/zxad192 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ajhp/advance-article-pdf/doi/10.1093/ajhp/zxad192/51272170/zxad192.pdf |
| OpenAlex ID | https://openalex.org/W4386196902 |
| PMID | 37632460 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Kristen Pogue](https://scholariq.org/researchers/kristen-pogue/)

## Paper journal

- [American Journal of Health-System Pharmacy](https://scholariq.org/journals/american-journal-of-health-system-pharmacy/)

## Paper primary topic

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Paper topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.